We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-11.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$842M
AUM Growth
-$295M
(-26%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-13.31%
Top 10 Holdings %
Top 10 Hldgs %
47.05%
Holding
143
New
42
Increased
27
Reduced
21
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$14M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$11.9M |
| 3 |
AMRN
Amarin Corp
AMRN
|
+$9.5M |
| 4 |
SI-BONE Inc
SIBN
|
+$9.49M |
| 5 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$7.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRFS
Grifois
GRFS
|
+$13.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$13.3M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
+$7.52M |
| 4 |
CONMED
CNMD
|
+$5.18M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$4.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.76% |
| 2 | Industrials | 1.16% |
| 3 | Consumer Staples | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $88.3M | 10.49% |
342,700
-143,500
| -30% | -$43.8M |
|
2
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
| $66.7M | 7.92% |
753,000
+350,000
| +87% | +$34M |
|
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $48M | 5.7% |
620,000
+192,000
| +45% | +$17M |
|
4
CALL
Medtronic
MDT
$112B
| $42.8M | 5.09% |
475,000
+209,000
| +79% | +$22.2M |
|
5
PUT
iShares Russell 2000 ETF
IWM
$83B
| $31.9M | 3.79% |
278,800
+20,800
| +8% | +$3.1M |
|
6
ICU Medical
ICUI
$4.61B
| $25.6M | 3.04% |
126,784
+23,464
| +23% | +$4.52M |
|
|
7
CALL
ICU Medical
ICUI
$4.61B
| $24.5M | 2.91% |
121,500
+50,500
| +71% | +$9.72M |
|
8
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.08B
| $24.4M | 2.9% |
330,000
+61,000
| +23% | +$4.96M |
|
9
Inspire Medical Systems
INSP
$1.74B
| $22M | 2.61% |
364,980
-18,660
| -5% | -$1.38M |
|
|
NSTG
10
DELISTED
NanoString Technologies, Inc.
NSTG
| $21.9M | 2.6% |
911,253
-53,317
| -6% | -$1.54M |
|
11
PUT
Eli Lilly
LLY
$1.06T
| $20.8M | 2.47% |
+150,000
| New | +$20.6M |
|
|
12
CALL
AtriCure
ATRC
$2.11B
| $19M | 2.25% |
+565,000
| New | +$20.3M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
| $18.7M | 2.22% |
207,996
+120,806
| +139% | +$11.9M |
|
|
INOV
14
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $18.4M | 2.18% |
1,104,040
+395,570
| +56% | +$7.51M |
|
|
ALXN
15
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $18M | 2.13% |
+200,000
| New | +$19.6M |
|
|
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
| $17.3M | 2.05% |
6,904,628
+551,689
| +9% | +$1.56M |
|
17
STAAR Surgical
STAA
$1.21B
| $15.8M | 1.87% |
488,950
-51,160
| -9% | -$1.72M |
|
|
IMDX
18
Insight Molecular Diagnostics
IMDX
$156M
| $13.7M | 1.62% |
278,914
-5,915
| -2% | -$290K |
|
|
19
AtriCure
ATRC
$2.11B
| $13.1M | 1.55% |
+388,994
| New | +$14M |
|
20
PUT
Invesco QQQ Trust
QQQ
$484B
| $12.9M | 1.53% |
+67,500
| New | +$14.3M |
|
21
Establishment Labs
ESTA
$2.28B
| $12.7M | 1.51% |
878,227
+195,627
| +29% | +$4.32M |
|
22
PUT
Sarepta Therapeutics
SRPT
$1.77B
| $12.7M | 1.5% |
129,400
+20,400
| +19% | +$2.33M |
|
|
ABMD
23
PUT
DELISTED
Abiomed Inc
ABMD
| $12.4M | 1.48% |
85,700
-91,300
| -52% | -$15.2M |
|
|
IVC
24
DELISTED
Invacare Corporation
IVC
| $11.9M | 1.42% |
1,607,846
+269,353
| +20% | +$2.09M |
|
25
Zimmer Biomet
ZBH
$18.4B
| $11.2M | 1.33% |
114,178
-20,536
| -15% | -$2.69M |
|
Similar funds
BCA
ONGA
RC
DOFI
SR
SCI
LPC
GBCP
Pura Vida Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Pura Vida Investments held 143 positions worth $842M, down 26% from $1.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Pura Vida Investments withdrew a net $112M in Q1 2020, closing 50 positions and reducing 21 holdings. Its most notable exit was Grifois, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Pura Vida Investments opened a new position in AtriCure worth $13.1M.
- Pura Vida Investments's largest Q1 2020 buy was AtriCure: 388,994 shares worth $13.1M.
- Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2020, an estimated $11.9M increase.
- Pura Vida Investments's biggest Q1 2020 reduction was DexCom, cutting an estimated $4.46M.
- Pura Vida Investments fully exited Grifois in Q1 2020, selling an estimated $13.5M.
- Pura Vida Investments's ten largest holdings make up 47% of its $842M portfolio in Q1 2020.
- Pura Vida Investments opened 42 new positions and closed 50 in Q1 2020.
- Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $842M.
Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.